Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma;”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00001439
What this trial is testing

A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant

Who this might be right for
Melanoma
National Cancer Institute (NCI) 255
Early research (Phase 1)Study completedNCT00815607
What this trial is testing

Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma

Who this might be right for
Melanoma
Alaunos Therapeutics 12
Not applicableLooking for participantsNCT06952400
What this trial is testing

The Registry Study of Genetic Alterations of Melanoma in Taiwan

Who this might be right for
Primary Melanoma of the Extremity
National Health Research Institutes, Taiwan 250
Not applicableUnknownNCT06273709
What this trial is testing

Remote Assessment of OCT Scans for BCC Detection

Who this might be right for
Basal Cell Carcinoma
Maastricht University Medical Center 120
Not applicableStudy completedNCT05712551
What this trial is testing

Dermoscopy Augmented Histology Trial, Consensus Agreement Diagnosis Made by Dermatopathology Experts

Who this might be right for
Melanoma (Skin)Pigmented Lesions
Herlev Hospital 4
Not applicableLooking for participantsNCT05527795
What this trial is testing

Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma

Who this might be right for
Melanoma
Hospices Civils de Lyon 1,000
Early research (Phase 1)Study completedNCT00698100
What this trial is testing

Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines

Who this might be right for
MelanomaSkin
Memorial Sloan Kettering Cancer Center 18
Not applicableEnded earlyNCT02650492
What this trial is testing

Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma

Who this might be right for
MelanomaMalignant Melanoma
Clinical Laserthermia Systems AB 2
Not applicableStudy completedNCT03040492
What this trial is testing

Vitamin D Receptor Polymorphisms and Non-Melanoma Skin Cancer Risk

Who this might be right for
Skin Cancer, Non-Melanoma
University of Alabama at Birmingham 200
Testing effectiveness (Phase 2)Study completedNCT01248936
What this trial is testing

RO5185426 in Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 374
Early research (Phase 1)Ended earlyNCT01216436
What this trial is testing

Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Duke University 2
Not applicableUnknownNCT05889481
What this trial is testing

Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma

Who this might be right for
Uveal Melanoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100
Testing effectiveness (Phase 2)Looking for participantsNCT06466434
What this trial is testing

Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma

Who this might be right for
Unresectable Melanoma
M.D. Anderson Cancer Center 75
Not applicableStudy completedNCT04435964
What this trial is testing

Gender Difference in sidE eFfects of ImmuNotherapy: a Possible Clue to Optimize cancEr tReatment

Who this might be right for
MelanomaLung CancerHead and Neck Cancer+2 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 247
Early research (Phase 1)Study completedNCT01893099
What this trial is testing

Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma

Who this might be right for
Ocular Melanoma
Centre Hospitalier Universitaire Vaudois 11
Early research (Phase 1)Study completedNCT00019175
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Recurrent Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01100528
What this trial is testing

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+1 more
Case Comprehensive Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT00257465
What this trial is testing

Trial of Autologous, Hapten-Modified Vaccine in Patients With Stage III or IV Melanoma

Who this might be right for
Melanoma
AVAX Technologies 82
Testing effectiveness (Phase 2)Ended earlyNCT00304200
What this trial is testing

Temodar and Sutent as Therapy for Melanoma

Who this might be right for
Metastatic Malignant Melanoma
Northern California Melanoma Center 7
Very early researchUnknownNCT05961111
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

Who this might be right for
SarcomaCarcinomaDigestive Cancer+7 more
Shanghai Yunying Medical Technology 20
Next Page